- Home
- LEGN vs COTY Comparison
LEGN vs COTY Comparison
Compare LEGN & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- COTY
- Stock Information
- Founded
- LEGN 2014
- COTY 1904
- Country
- LEGN United States
- COTY United States
- Employees
- LEGN N/A
- COTY N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- COTY Package Goods/Cosmetics
- Sector
- LEGN Health Care
- COTY Consumer Discretionary
- Exchange
- LEGN Nasdaq
- COTY Nasdaq
- Market Cap
- LEGN 5.4B
- COTY 4.4B
- IPO Year
- LEGN 2020
- COTY 2013
- Fundamental
- Price
- LEGN $38.80
- COTY $4.73
- Analyst Decision
- LEGN Strong Buy
- COTY Buy
- Analyst Count
- LEGN 11
- COTY 15
- Target Price
- LEGN $74.60
- COTY $7.43
- AVG Volume (30 Days)
- LEGN 1.4M
- COTY 7.3M
- Earning Date
- LEGN 08-11-2025
- COTY 08-20-2025
- Dividend Yield
- LEGN N/A
- COTY N/A
- EPS Growth
- LEGN N/A
- COTY N/A
- EPS
- LEGN N/A
- COTY N/A
- Revenue
- LEGN $728,303,000.00
- COTY $6,003,900,000.00
- Revenue This Year
- LEGN $65.33
- COTY N/A
- Revenue Next Year
- LEGN $54.68
- COTY $1.33
- P/E Ratio
- LEGN N/A
- COTY N/A
- Revenue Growth
- LEGN 112.46
- COTY N/A
- 52 Week Low
- LEGN $27.34
- COTY $4.46
- 52 Week High
- LEGN $59.62
- COTY $10.30
- Technical
- Relative Strength Index (RSI)
- LEGN 47.38
- COTY 41.32
- Support Level
- LEGN $38.53
- COTY $4.89
- Resistance Level
- LEGN $45.30
- COTY $5.15
- Average True Range (ATR)
- LEGN 1.76
- COTY 0.16
- MACD
- LEGN -0.61
- COTY -0.02
- Stochastic Oscillator
- LEGN 9.73
- COTY 12.50
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About COTY Coty Inc.
Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to launch makeup products bearing her name. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.